ArticleAlzheimer's & dementia (New York, N. Y.)2020

Safety and pharmacokinetics of the orally available antiprionic compound PRI-002: A single and multiple ascending dose phase I study.

Janine Kutzsche et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.